Showing results (491-500 of 3,180) with videos related to
Sort By:
Pageof 318
Molecular Cancer Research : MCR|May 15, 2013
Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell deathBenjamin Theobald, Kathy Bonness, Alla Musiyenko, et al.Molecular Cancer Research : MCR|April 26, 2013
Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapyGabriela Schneider, Ewa Bryndza, Ahmed Abdel-Latif, et al.Molecular Cancer Research : MCR|April 19, 2013
Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expressionKazuyuki Matsushita, Mai Tamura, Nobuko Tanaka, et al.Molecular Cancer Research : MCR|March 16, 2013
PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortalityEric G Bluemn, Elysia Sophie Spencer, Brigham Mecham, et al.Molecular Cancer Research : MCR|February 5, 2013
Procollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasisDaniele M Gilkes, Saumendra Bajpai, Carmen C Wong, et al.Molecular Cancer Research : MCR|February 5, 2013
EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancerNarendra V Sankpal, Timothy P Fleming, William E GillandersMolecular Cancer Research : MCR|February 5, 2013
The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expressionKaushal Asrani, Ruth A Keri, Rebeca Galisteo, et al.Molecular Cancer Research : MCR|February 1, 2013
Effects of simultaneous knockdown of HER2 and PTK6 on malignancy and tumor progression in human breast cancer cellsNatalie Ludyga, Natasa Anastasov, Michael Rosemann, et al.Molecular Cancer Research : MCR|February 27, 2013
CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cellsYuri Miyazawa, Takamasa Uekita, Yuumi Ito, et al.Molecular Cancer Research : MCR|January 11, 2013
A modified HSP70 inhibitor shows broad activity as an anticancer agentGregor M Balaburski, Julia I-Ju Leu, Neil Beeharry, et al.Pageof 318